Literature DB >> 8353052

The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck.

L J Clark1, K Edington, I R Swan, K A McLay, W J Newlands, L C Wills, H A Young, P W Johnston, R Mitchell, G Robertson.   

Abstract

We have examined the incidence of Harvey ras mutations in human squamous cell carcinomas (SCC) of the upper aerodigestive tract using the polymerase chain reaction (PCR) followed by direct sequencing. No mutations were detected at codons 12, 13, 59 or 61 of this gene in any of six papillomas, five erythroplakias, 56 squamous cell carcinomas, and 16 SCC cell lines. Some of the SCC were lymph node metastases (three) or tumours which had recurred following radiotherapy (seven). We conclude that Harvey ras mutations are not a common event in the pathogenesis or recurrence of SCCs from Caucasian subjects, in contrast to the situation with Indian populations (Saranath et al., 1991).

Entities:  

Mesh:

Year:  1993        PMID: 8353052      PMCID: PMC1968389          DOI: 10.1038/bjc.1993.396

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

Review 1.  SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS.

Authors:  R K BOUTWELL
Journal:  Prog Exp Tumor Res       Date:  1964

2.  Southern blot analysis of DNA extracted from formalin-fixed pathology specimens.

Authors:  L Dubeau; L A Chandler; J R Gralow; P W Nichols; P A Jones
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

3.  Smoking and laryngeal cancer.

Authors:  P M Stell
Journal:  Lancet       Date:  1972-03-18       Impact factor: 79.321

4.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

5.  Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors.

Authors:  B Ozanne; R J Fulton; P L Kaplan
Journal:  J Cell Physiol       Date:  1980-10       Impact factor: 6.384

6.  Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas.

Authors:  A Balmain; M Ramsden; G T Bowden; J Smith
Journal:  Nature       Date:  1984 Feb 16-22       Impact factor: 49.962

7.  Benzo(a)pyrene metabolism and DNA adduct formation in serially cultivated strains of human epidermal keratinocytes.

Authors:  E K Parkinson; R F Newbold
Journal:  Int J Cancer       Date:  1980-09-15       Impact factor: 7.396

8.  The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients.

Authors:  C Paraskeva; B G Buckle; D Sheer; C B Wigley
Journal:  Int J Cancer       Date:  1984-07-15       Impact factor: 7.396

9.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cells.

Authors:  K Alitalo; E Kuismanen; R Myllylä; U Kiistala; S Asko-Seljavaara; A Vaheri
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

View more
  10 in total

Review 1.  Dysregulated molecular networks in head and neck carcinogenesis.

Authors:  Alfredo A Molinolo; Panomwat Amornphimoltham; Cristiane H Squarize; Rogerio M Castilho; Vyomesh Patel; J Silvio Gutkind
Journal:  Oral Oncol       Date:  2008-09-19       Impact factor: 5.337

Review 2.  Emerging strategies for the early detection and prevention of head and neck squamous cell cancer.

Authors:  Santanu Dasgupta; Rupesh Dash; Swadesh K Das; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 3.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

4.  PTEN deficiency contributes to the development and progression of head and neck cancer.

Authors:  Cristiane H Squarize; Rogerio M Castilho; Aline C Abrahao; Alfredo Molinolo; Mark W Lingen; J Silvio Gutkind
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

5.  Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.

Authors:  Lisa A Elferink; Vicente A Resto
Journal:  J Signal Transduct       Date:  2011-06-07

6.  The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.

Authors:  A Malliri; M Symons; R F Hennigan; A F Hurlstone; R F Lamb; T Wheeler; B W Ozanne
Journal:  J Cell Biol       Date:  1998-11-16       Impact factor: 10.539

7.  Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck.

Authors:  H Kiaris; D A Spandidos; A S Jones; E D Vaughan; J K Field
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

8.  The p53 status of cultured human premalignant oral keratinocytes.

Authors:  J E Burns; L J Clark; W A Yeudall; R Mitchell; K Mackenzie; S E Chang; E K Parkinson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

9.  Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.

Authors:  P Stanton; S Richards; J Reeves; M Nikolic; K Edington; L Clark; G Robertson; D Souter; R Mitchell; F J Hendler
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

10.  Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts.

Authors:  M S Fahey; I C Paterson; A Stone; A J Collier; Y L Heung; M Davies; V Patel; E K Parkinson; S S Prime
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.